Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: J Neurosci Res. 2009 Jan;87(1):86–95. doi: 10.1002/jnr.21836

Fig.3.

Fig.3

DETA-NONOate treatment upregulates chemokine (CXC motif) receptor 4 (CXCR4) and Tie2 in the SVZ after stroke in mice. A-D and F-I: CXCR4 and Tie2 immunostaining in the SVZ in sham control (A and F); sham + DETA-NONOate (B and G); MCAo control (C and H) and MCAo + DETA-NONOate treatment (D and I). E and J: Quantitative data of CXCR4 (E) and Tie2 (J) immunoreactive positive area. K-P: CXCR4 (K-M) and Tie2 (N-P) double-immunofluorecence staining with DCX in the SVZ. Bar in D = 50 μm; Bar in I = 25 μm.